Sun Pharma Q1 PAT may dip 15.5% YoY to Rs 1,673.1 cr: ICICI Direct

ICICI Direct has come out with its first quarter (April-June’ 22) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Sun Pharma to report net profit at Rs 1,673.1 crore down 15.5% year-on-year (down 5.8% quarter-on-quarter).

Net Sales are expected to increase by 6.8 percent Y-o-Y (up 9.9 percent Q-o-Q) to Rs 10,382.7 crore, according to ICICI Direct.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 10.3 percent Y-o-Y (up 8.1 percent Q-o-Q) to Rs 2,529.9 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.